TCT 321: FFR-guided PCI Optimization Directed by High-Definition IVUS Versus Standard of Care: 3-Year Results From the FFR REACT Trial

Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:

• Grant Support/Research Contract - Boston Scientific Corporation; ACIST; Medtronic; Pie Medical; Recor Medical
• Consultant Fee/Honoraria/Speaker's Bureau - ACIST; Boston Scientific Corporation; Recor Medical; Pie Medical; Medtronic; PulseCath BV